In this “Your Stories” podcast from Conquer Cancer, the ASCO Foundation, Bill Coulbourne discusses supporting his wife and her cancer advocacy.
Journalist Loriana Hernandez-Aldama wasn’t expecting to hear she had cancer again -- and it was a different type than her first diagnosis. Here’s how she learned to cope with her secondary cancer diagnosis and prepare for treatment.
Dr. Norah Lynn Henry discusses 4 research findings from the 2019 San Antonio Breast Cancer Symposium for the treatment of various types of breast cancer.
In these “Your Stories” podcasts from Conquer Cancer, the ASCO Foundation, individuals share their experiences with coping with the loss of a loved one from cancer.
In this month’s From the Editor’s Desk, Dr. Schapira writes about the challenges of living with metastatic breast cancer.
Blood Tests to Find Cancer and Precision Radiation Therapy: Research from the ASCO Breakthrough Global Summit
Research from the ASCO Breakthrough global summit highlights innovations in blood tests to find cancer and using genetic markers to personalize the use of radiation therapy.
Breast cancer survivor Kate Sweitzer knew complementary and alternative therapies couldn’t replace her standard cancer treatment, but she was passionate about including other therapies in her care. Learn how she did so safely by working closely with her oncologist.
Cancer.Net Associate Editors share new insights from research presented at the 2019 ASCO Annual Meeting.
ASCO Annual Meeting 2019: Immunotherapy for Lung Cancer, Gastrointestinal Cancers and Targeted Therapy for Breast Cancer
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include treatment advances for advanced lung cancer, stomach cancer, gastroesophageal junction cancer, and breast cancer.
Read research highlights that will be presented at the 2019 ASCO Annual Meeting, covering low-fat diets and risk of breast cancer death, chemotherapy for older adults with esophageal cancer, targeted therapy for those at risk for multiple myeloma, the rate of genetic changes in childhood cancers, and a new targeted therapy for childhood central nervous system tumors.